Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Minerva Neurosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 35 | 33 | −2 |
| Shares | 20.7M | 19.7M | −1.06M (−5.1%) |
| Value | $16.6M | $16.3M | −$275.0K (−1.7%) |
New holders (4)
Institutions that held Minerva Neurosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bailard, Inc. | 24,400 | $20.0K | 0.00% |
| Two Sigma Securities, LLC | 17,123 | $14.0K | 0.00% |
| JPMorgan Chase & Co | 647 | $1.00K | 0.00% |
| Simplex Trading, LLC | 45 | $0 | 0.00% |
Sold out (6)
Institutions that held Minerva Neurosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Dimensional Fund Advisors LP | 350,234 | $281.0K |
| Virtu Financial LLC | 30,096 | $24.0K |
| Raymond James Financial Services Advisors, Inc. | 20,000 | $16.0K |
| Group One Trading, L.P. | 10,795 | $9.00K |
| Jane Street Group, LLC | 10,923 | $9.00K |
| Aquatic Capital Management LLC | 2,200 | $2.00K |